Close
Nordic 9Nordic 9

M&L Healthcare (investor - Others)

Singapore mnlhealthcare.com
See something wrong or missing? Let us know
Offices:Singapore

M&L Healthcare is a Singapore based family office focused on long-term investments in the healthcare sector.

Average round investment:31.31M USD
Average number per year:1.5
Distribution: 2025 (1)2024 (2)
Portfolio companies: France SafeHealSwitzerland CorFlow TherapeuticsFrance Hepta Medical
Mostly invests in: France France (2) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to M&L Healthcare

Name Criteria
United States Illumina Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States TransLink Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Belgium Bioqube Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Germany Evonik Venture Capital GmbH
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Hardware, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Belgium European Investment Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
France Merieux Equity Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Hardware, Biotech
  • Similar business models: B2B
  • Common investees countries: France, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Omega Funds
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Hardware, Biotech
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Luxembourg Alpha Intelligence Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Jolt Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States +ND Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top